Association of common ATM polymorphism with bilateral breast cancer

被引:39
作者
Heikkinen, K [1 ]
Rapakko, K [1 ]
Karppinen, SM [1 ]
Erkko, H [1 ]
Nieminen, P [1 ]
Winqvist, R [1 ]
机构
[1] Univ Oulu, Oulu Univ Hosp, Dept Clin Genet, FIN-90029 Oulu, Finland
关键词
breast cancer susceptibility; ataxia-telangiectasia; genome integrity maintenance; DNA double-strand break repair;
D O I
10.1002/ijc.20996
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The ATM kinase has an essential role in maintaining genomic integrity. Loss of both ATM alleles results in ataxia-telangiectasia (A-T), a rare autosomal recessive neuroimmunologic disorder associated with cancer susceptibility. Individuals heterozygous for germline ATM mutations have been reported to have an increased risk for malignancy, in particular, female breast cancer. In the current study, a full mutation analysis of the ATM gene was carried out in patients from 121 breast or breast-ovarian cancer families. We discovered that the combination of 5557G -> A in cis position with IVS38-8 T -> C was associated with bilateral breast cancer (OR = 10.2; 95% CI = 3.1-33.8; p = 0.001). As the 5557G -> A change has been reported to affect an exonic splicing enhancer, we hypothesized that the observed composite allele could have some effect on the correct splicing of exon 39. However, no aberrant transcripts were detected, but ATM expression levels of lymphoblast cell lines from heterozygous carriers of this combination allele were lower than from noncarriers (p = 0.09). Lowered gene expression levels may have direct influence on the activities in DNA damage recognition and response pathways, as well as other genome integrity maintenance functions. Based on the results, we propose a cancer risk-modifying effect for the ATM 5557G -> A, IVS38-8T -> C composite allele. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:69 / 72
页数:4
相关论文
共 29 条
  • [1] ATM mutations in Finnish breast cancer patients
    Allinen, M
    Launonen, V
    Laake, K
    Jansen, L
    Huusko, P
    Kääriäinen, H
    Borresen-Dale, AL
    Winqvist, R
    [J]. JOURNAL OF MEDICAL GENETICS, 2002, 39 (03) : 192 - 196
  • [2] ATM polymorphisms as risk factors for prostate cancer development
    Angèle, S
    Falconer, A
    Edwards, SM
    Dörk, T
    Bremer, M
    Moullan, N
    Chapot, B
    Muir, K
    Houlston, R
    Norman, AR
    Bullock, S
    Hope, Q
    Meitz, J
    Dearnaley, D
    Dowe, A
    Southgate, C
    Ardern-Jones, A
    Easton, DF
    Eeles, RA
    Hall, J
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (04) : 783 - 787
  • [3] Angèle S, 2003, CANCER RES, V63, P8717
  • [4] Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases
    Blencowe, BJ
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (03) : 106 - 110
  • [5] Listening to silence and understanding nonsense: Exonic mutations that affect splicing
    Cartegni, L
    Chew, SL
    Krainer, AR
    [J]. NATURE REVIEWS GENETICS, 2002, 3 (04) : 285 - 298
  • [6] Dörk T, 2001, CANCER RES, V61, P7608
  • [7] CANCER RISKS IN A-T HETEROZYGOTES
    EASTON, DF
    [J]. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1994, 66 (06) : S177 - S182
  • [8] An update on conformation sensitive gel electrophoresis
    Ganguly, A
    [J]. HUMAN MUTATION, 2002, 19 (04) : 334 - 342
  • [9] Evidence of founder mutations in Finnish BRCA1 and BRCA2 families
    Huusko, P
    Pääkkönen, K
    Launonen, V
    Pöyhönen, M
    Blanco, G
    Kauppila, A
    Puistola, U
    Kiviniemi, H
    Kujala, M
    Leisti, J
    Winqvist, R
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (06) : 1544 - 1548
  • [10] Germ-line TP53 mutations in Finnish cancer families exhibiting features of the Li-Fraumeni syndrome and negative for BRCA1 and BRCA2
    Huusko, P
    Castrén, K
    Launonen, V
    Soini, Y
    Pääkkönen, K
    Leisti, J
    Vähäkangas, K
    Winqvist, R
    [J]. CANCER GENETICS AND CYTOGENETICS, 1999, 112 (01) : 9 - 14